A detailed history of Kennedy Capital Management, Inc. transactions in Atri Cure, Inc. stock. As of the latest transaction made, Kennedy Capital Management, Inc. holds 579,932 shares of ATRC stock, worth $22.9 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares
579,932
Previous 508,627 14.02%
Holding current value
$22.9 Million
Previous $11.6 Million 40.41%
% of portfolio
0.38%
Previous 0.27%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$20.34 - $29.5 $1.45 Million - $2.1 Million
71,305 Added 14.02%
579,932 $16.3 Million
Q2 2024

Aug 14, 2024

BUY
$19.86 - $29.09 $5.59 Million - $8.19 Million
281,434 Added 123.87%
508,627 $11.6 Million
Q1 2024

May 15, 2024

BUY
$28.21 - $37.78 $3.43 Million - $4.6 Million
121,752 Added 115.47%
227,193 $6.91 Million
Q4 2023

Feb 14, 2024

BUY
$32.99 - $43.25 $605,762 - $794,156
18,362 Added 21.09%
105,441 $3.76 Million
Q3 2023

Nov 14, 2023

BUY
$41.12 - $57.73 $566,263 - $794,999
13,771 Added 18.79%
87,079 $3.81 Million
Q2 2023

Aug 14, 2023

BUY
$40.44 - $49.6 $1.55 Million - $1.9 Million
38,298 Added 109.39%
73,308 $3.62 Million
Q1 2023

May 15, 2023

SELL
$35.87 - $47.22 $130,638 - $171,975
-3,642 Reduced 9.42%
35,010 $1.45 Million
Q4 2022

Feb 14, 2023

SELL
$33.48 - $47.45 $73,990 - $104,864
-2,210 Reduced 5.41%
38,652 $1.72 Million
Q3 2022

Nov 14, 2022

SELL
$38.25 - $52.62 $12,431 - $17,101
-325 Reduced 0.79%
40,862 $1.6 Million
Q2 2022

Aug 10, 2022

SELL
$35.1 - $66.01 $13,618 - $25,611
-388 Reduced 0.93%
41,187 $1.68 Million
Q1 2022

May 16, 2022

SELL
$57.43 - $71.39 $2.62 Million - $3.26 Million
-45,673 Reduced 52.35%
41,575 $2.73 Million
Q4 2021

Feb 14, 2022

BUY
$63.4 - $87.14 $2.5 Million - $3.43 Million
39,357 Added 82.18%
87,248 $6.07 Million
Q3 2021

Nov 15, 2021

SELL
$69.28 - $84.46 $115,004 - $140,203
-1,660 Reduced 3.35%
47,891 $3.33 Million
Q2 2021

Aug 16, 2021

SELL
$64.13 - $80.18 $1.01 Million - $1.26 Million
-15,764 Reduced 24.14%
49,551 $3.93 Million
Q1 2021

May 14, 2021

SELL
$53.79 - $66.98 $2.29 Million - $2.86 Million
-42,630 Reduced 39.49%
65,315 $4.28 Million
Q4 2020

Feb 12, 2021

SELL
$34.56 - $57.55 $115,464 - $192,274
-3,341 Reduced 3.0%
107,945 $6.01 Million
Q3 2020

Nov 16, 2020

BUY
$38.36 - $46.91 $1.8 Million - $2.21 Million
47,035 Added 73.21%
111,286 $4.44 Million
Q2 2020

Aug 14, 2020

BUY
$31.78 - $51.19 $831,746 - $1.34 Million
26,172 Added 68.73%
64,251 $2.89 Million
Q1 2020

May 15, 2020

BUY
$24.49 - $43.84 $932,554 - $1.67 Million
38,079 New
38,079 $1.28 Million
Q2 2019

Aug 14, 2019

SELL
$26.85 - $30.74 $6.52 Million - $7.47 Million
-242,951 Closed
0 $0
Q1 2019

May 13, 2019

SELL
$26.38 - $33.34 $589,170 - $744,615
-22,334 Reduced 8.42%
242,951 $6.51 Million
Q4 2018

Feb 12, 2019

BUY
$26.66 - $34.85 $7.07 Million - $9.25 Million
265,285 New
265,285 $8.12 Million

Others Institutions Holding ATRC

About AtriCure, Inc.


  • Ticker ATRC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 46,424,700
  • Market Cap $1.83B
  • Description
  • AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...
More about ATRC
Track This Portfolio

Track Kennedy Capital Management, Inc. Portfolio

Follow Kennedy Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kennedy Capital Management, Inc. with notifications on news.